|Articles|January 19, 2023
Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies
Author(s)Curia
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
